Potassium Ion

Potassium Ion

SCHEMBL830613

Cc1cccc(-c2cc(CC(C)C)c(C(=O)[O-])c(C(F)(F)F)n2)c1.[K+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SDHB P21912 1/20 0.40
TRPV1 Q8NER1 11/20 0.37
KMO O15229 1/20 0.36
DHODH Q02127 1/20 0.35
ENPP1 P22413 1/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
GFER P55789 1/20 0.34
KMT2A Q03164 1/20 0.34
DPP4 P27487 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839855 0.89 GFER (0.42) SDHBTRPV1KMODHODHENPP1
Potassium SCHEMBL830614 0.88 GFER (0.41) SDHBTRPV1KMODHODHENPP1
SCHEMBL830612 0.88 GFER (0.41) SDHBTRPV1KMODHODHENPP1
Potassium Ion SCHEMBL830772 0.88 DPP4 (0.37) SDHBDHODHALDH1A1DPP4
SCHEMBL830007 0.85 ALDH1A1 (0.43) SDHBMEN1ALDH1A1LMNAHPGD
Potassium Ion SCHEMBL829507 0.84 PTGER1 (0.41) DHODHALDH1A1
SCHEMBL839634 0.77 DPP4 (0.46) SDHBDHODHGFERDPP4
SCHEMBL830771 0.76 DPP4 (0.45) SDHBDHODHGFERDPP4
SCHEMBL831905 0.73 KMO (0.45) KMODHODHALDH1A1DPP4
SCHEMBL831044 0.73 ALDH1A1 (0.50) MEN1ALDH1A1LMNAHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143411-B2 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2012-03-27 US disclosed
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use SLC5A6, FABP3, NAPRT SDHB 1866/4885TRPV1 3664/4885KMO 2954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.